Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2003
12/18/2003CA2488602A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488567A1 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003CA2488402A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003CA2488367A1 Antiallergic agents
12/18/2003CA2488358A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
12/18/2003CA2488356A1 Novel therapeutic use of polypodium extracts
12/18/2003CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2486362A1 Novel recombinant anticoagulant proteins
12/18/2003CA2483555A1 Gamma lactams as prostaglandin agonists and use thereof
12/17/2003EP1371648A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/17/2003EP1371647A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates
12/17/2003EP1371645A1 Process for the preparation of the 2'-(R)-Glycopyrronium Enantiomers and their use in medicaments
12/17/2003EP1371370A1 Drugs containing reduced vitamin b2
12/17/2003EP1371367A1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases
12/17/2003EP1371289A1 Choline-silicic acid complex
12/17/2003EP1370685A2 Diagnosis of diseases associated with dna repair
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370568A1 Chemical compounds
12/17/2003EP1370561A2 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370553A2 Rho-kinase inhibitors
12/17/2003EP1370552A2 Rho-kinase inhibitors
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370540A1 Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370526A1 Diamides which inhibit tryptase and factor xa activity
12/17/2003EP1370521A1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/17/2003EP1370518A2 Tryptase-inhibitors
12/17/2003EP1370293A2 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1370264A2 Nicotinic receptor agonists for the treatment of inflammatory diseases
12/17/2003EP1370258A2 Peptide deformylase inhibitors
12/17/2003EP1370246A2 Modulation of release from dry powder formulations
12/17/2003EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
12/17/2003EP1272470B1 Amorphous torasemide modification
12/17/2003EP1224210B1 Basic monocyclic compounds having nk2 antagonist action, processes for their preparation, and formulations containing them
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1162970B1 Anti-inflammatory uses of manzamines
12/17/2003EP1147121B1 Ketolide antibiotics
12/17/2003EP1082302B1 A vla-4 inhibitor: omepupa-v
12/17/2003EP1066043B1 Materials for the treatment of conditions involving mast cells, basophils and eosinophils
12/17/2003EP0984981B1 Anti-inflammatory tyrosine derivatives
12/17/2003EP0937075B1 New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
12/17/2003CN1461653A Traditional Chinese medicine prepn. for treating bronchial asthma
12/17/2003CN1461604A Health-care food with functions of anti-senility, beautifying face and moistening skin and prepn. method therefor
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/17/2003CN1131062C Chinese medicine for treating trachitis
12/17/2003CN1131044C External-use medicine for treating cough and diarrhoea in thd four seasons
12/17/2003CN1131029C Application of dihydromyricetrin in medicine for preparation of hepatitis
12/16/2003US6664393 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/16/2003US6664264 Thioether substituted imidazoquinolines
12/16/2003US6664252 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664230 Orally administered peptides to ameliorate atherosclerosis
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
12/16/2003US6663889 Ambroxol-containing lozenge
12/16/2003US6663878 Anti-inflammatory bioactive glass particulates
12/11/2003WO2003102237A1 Treatment with cytokines
12/11/2003WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003WO2003102138A2 Elongase genes and uses thereof
12/11/2003WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003WO2003101989A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
12/11/2003WO2003101970A1 Imidazolium cxcr3 inhibitors
12/11/2003WO2003101964A1 Piperidine derivative, process for producing the same, and use
12/11/2003WO2003101961A1 Novel substituted indoles
12/11/2003WO2003101957A1 New salts
12/11/2003WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003WO2003101464A1 Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food
12/11/2003WO2003101456A1 Use of compounds that stimulate cgmp
12/11/2003WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/11/2003WO2003101424A1 Modified release pharmaceutical formulation
12/11/2003WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof
12/11/2003WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
12/11/2003WO2003063772A3 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
12/11/2003WO2003026579A3 Combination therapies for immune mediated diseases
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003WO2003004460A3 Succinic acid derivatives
12/11/2003WO2003000727A3 Atopy
12/11/2003WO2003000241A3 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases
12/11/2003WO2002094273A3 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
12/11/2003WO2002094176A3 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments
12/11/2003WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003WO2002067986A3 Symbiotic regenerative agent
1 ... 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 ... 878